新关注 > 信息聚合 > “中国医改面临体制与法规改革两大核心问题”

“中国医改面临体制与法规改革两大核心问题”

"China faces medical reform system and regulatory reform two core issues"

2015-10-27 03:16:35来源: 和讯网

10月14日,辉瑞公司董事长兼CEO晏瑞德(Ian Read)在纽约出席美中关系全国委员会颁奖晚宴。 晏瑞德表示,中国医药法规体系改革还有提升空间。 10月14日,辉瑞公司董事长兼CEO晏瑞...

10 14, Pfizer, chairman and CEO of Yan Ruide Ian read in New York attended the National Committee on us China relations at the gala dinner. Yan Ruide said that the reform of China's pharmaceutical laws and regulations as there is room for improvement. In October 14th, Pfizer Inc chairman and CEO yanrui...